IRIS UniCatt

Baranello, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.337
EU - Europa 2.074
AS - Asia 1.956
SA - Sud America 428
AF - Africa 60
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 6.863
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.247
SG - Singapore 930
DE - Germania 844
CN - Cina 546
BR - Brasile 350
SE - Svezia 268
IT - Italia 187
FR - Francia 147
GB - Regno Unito 128
UA - Ucraina 100
IE - Irlanda 98
VN - Vietnam 86
IN - India 82
ID - Indonesia 65
FI - Finlandia 62
RU - Federazione Russa 55
CA - Canada 44
HK - Hong Kong 39
PL - Polonia 38
KR - Corea 36
AR - Argentina 31
TR - Turchia 30
MX - Messico 27
JP - Giappone 26
BD - Bangladesh 25
BE - Belgio 23
IQ - Iraq 23
NL - Olanda 23
AT - Austria 16
EC - Ecuador 14
ZA - Sudafrica 14
ES - Italia 12
MK - Macedonia 12
RS - Serbia 12
CH - Svizzera 11
EG - Egitto 10
CO - Colombia 9
LT - Lituania 8
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
CZ - Repubblica Ceca 7
MA - Marocco 7
PE - Perù 7
PK - Pakistan 7
TN - Tunisia 7
VE - Venezuela 7
CI - Costa d'Avorio 6
PA - Panama 6
IL - Israele 5
IR - Iran 5
PH - Filippine 5
CL - Cile 4
KE - Kenya 4
PY - Paraguay 4
AU - Australia 3
BG - Bulgaria 3
CR - Costa Rica 3
DK - Danimarca 3
JO - Giordania 3
LV - Lettonia 3
MY - Malesia 3
SA - Arabia Saudita 3
SN - Senegal 3
TH - Thailandia 3
TW - Taiwan 3
AM - Armenia 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GE - Georgia 2
GR - Grecia 2
KG - Kirghizistan 2
LU - Lussemburgo 2
NG - Nigeria 2
NI - Nicaragua 2
NO - Norvegia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BO - Bolivia 1
CG - Congo 1
CY - Cipro 1
GT - Guatemala 1
HT - Haiti 1
JM - Giamaica 1
KY - Cayman, isole 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
ME - Montenegro 1
MO - Macao, regione amministrativa speciale della Cina 1
MT - Malta 1
NE - Niger 1
Totale 6.857
Salva come PNG Salva come JPEG
Città #
Singapore 488
Chandler 316
Ashburn 263
New York 142
Frankfurt am Main 139
Hefei 105
Los Angeles 99
Beijing 97
Dublin 81
Jacksonville 68
Munich 63
Jakarta 61
Ann Arbor 55
Dallas 50
San Mateo 47
São Paulo 46
Milan 40
Nürnberg 40
Chicago 39
Dearborn 38
Hong Kong 38
Marseille 38
Boston 37
Seattle 37
Wilmington 36
Rome 35
Seoul 35
Ho Chi Minh City 34
Nanjing 33
Moscow 29
Buffalo 27
Houston 27
Tokyo 26
Kent 25
Warsaw 24
Montreal 22
Woodbridge 21
Brussels 20
Princeton 20
Hanoi 19
Denver 18
Fairfield 18
Helsinki 18
London 18
Turku 18
Atlanta 17
Lancaster 17
Nuremberg 17
Santa Clara 17
Bremen 16
Brooklyn 16
Nanchang 16
Paris 15
Poplar 15
Chennai 14
Rio de Janeiro 14
Augusta 13
Johannesburg 13
Stockholm 13
Amsterdam 12
Düsseldorf 12
Lawrence 12
Orem 12
Palermo 12
Pune 12
Baghdad 11
Mexico City 11
Leawood 10
Redwood City 10
Skopje 10
Boardman 9
Changsha 9
Hangzhou 9
Norwalk 9
Hebei 8
Manchester 8
Phoenix 8
San Francisco 8
Secaucus 8
Vienna 8
Ankara 7
Brasília 7
Dhaka 7
Haiphong 7
Jinan 7
Lima 7
Portsmouth 7
Salvador 7
Tashkent 7
Abidjan 6
Belo Horizonte 6
Cairo 6
Cambridge 6
Curitiba 6
Fremont 6
Istanbul 6
Jiaxing 6
Lappeenranta 6
Lauterbourg 6
Menlo Park 6
Totale 3.500
Salva come PNG Salva come JPEG
Nome #
Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial 278
Cortical visual function in preterm infants in the first year. 262
Neurological examination at 6 to 9 months in infants with cystic periventricular leukomalacia 207
Prognostic value of EEG performed at term age in preterm infants. 204
-Thalamic atrophy in infants with PVL and cerebral visual impairment 180
External hydrocephalus in discordant birth weight twins: a case report 166
Visual development in prenatal post-haemorragic ventricular dilatation 161
Sleep disturbances in preschool age children with cerebral palsy: a questionnaire study 157
Early development in Dravet syndrome; visual function impairment precedes cognitive decline 153
Antenatal post-hemorragic ventriculomegaly: a prospective follow-up study 149
Sleep disturbances in preschool age children with cerebral palsy: a questionnaire study 145
Visual processing in Noonan syndrome: dorsal and ventral stream sensitivity 139
SMA-miRs (MiR-181a- 5p, -324-5p, and -451a) are overexpressed in spinal muscular atrophy skeletal muscle and serum samples 135
Different trajectories in upper limb and gross motor function in spinal muscular atrophy 134
Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes 133
SMA-miRs (MiR-181a- 5p, -324-5p, and -451a) are overexpressed in spinal muscular atrophy skeletal muscle and serum samples 133
Cardiac Function in Types II and III Spinal Muscular Atrophy: Should We Change Standars of Care? 131
Longitudinal evaluation of SMN levels as biomarker for spinal muscular atrophy: results of a phase IIb double-blind study of salbutamol 129
Risdiplam in types 2 and 3 spinal muscular atrophy: A randomised, placebo-controlled, dose-finding trial followed by 24 months of treatment 127
The nonsense mutation stop+4 model correlates with motor changes in Duchenne muscular dystrophy 127
Visual processing in Noonan syndrome: dorsal and ventral stream sensitivity 122
Upper limb function in Duchenne muscular dystrophy: 24 month longitudinal data. 122
Timed Rise from Floor as a Predictor of Disease Progression in Duchenne Muscular Dystrophy: An Observational Study 117
Gain and loss of upper limb abilities in Duchenne muscular dystrophy patients: A 24-month study 116
Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls 114
antenatal post hemorrhagic ventriculomegaly: a prospective follow up study 114
6 minute walk test in duchenne MD patients with different mutations:12 month changes 114
Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls 113
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial 112
Health-related quality of life and functional changes in DMD: A 12-month longitudinal cohort study 105
Longitudinal Analysis of PUL 2.0 Domains in Ambulant and Non-Ambulant Duchenne Muscular Dystrophy Patients: How do they Change in Relation to Functional Ability? 104
Revised north star ambulatory assessment for young boys with Duchenne muscular dystrophy 103
2-Year Change in Revised Hammersmith Scale Scores in a Large Cohort of Untreated Paediatric Type 2 and 3 SMA Participants 102
Type I spinal muscular atrophy and disease modifying treatments: a nationwide study in children born since 2016 102
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial 100
Longitudinal natural history in young boys with Duchenne muscular dystrophy 97
Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls 95
Genetic modifiers of upper limb function in Duchenne muscular dystrophy 94
The emerging spectrum of neurodevelopmental comorbidities in early-onset Spinal Muscular Atrophy 94
Categorizing natural history trajectories of ambulatory function measured by the 6-minute walk distance in patients with Duchenne muscular dystrophy 92
Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes 91
Implicit learning deficit in children with Duchenne muscular dystrophy: Evidence for a cerebellar cognitive impairment? 90
Registries versus tertiary care centers: How do we measure standards of care in Duchenne muscular dystrophy? 86
Safety and efficacy of risdiplam in patients with type 1 spinal muscular atrophy (FIREFISH part 2): secondary analyses from an open-label trial 84
Development of an International SMA Bulbar Assessment for Inter-professional Administration 84
Benefits of glucocorticoids in non-ambulant boys/men with Duchenne muscular dystrophy: A multicentric longitudinal study using the Performance of Upper Limb test 81
Longitudinal Analysis of PUL 2.0 Domains in Ambulant and Non-Ambulant Duchenne Muscular Dystrophy Patients: How do they Change in Relation to Functional Ability? 81
null 81
Risdiplam in Type 1 Spinal Muscular Atrophy 80
Correction to: Two‑year efficacy and safety of risdiplam in patients with type 2 or non‑ambulant type 3 spinal muscular atrophy (SMA) 77
Longitudinal data of neuropsychological profile in a cohort of Duchenne muscular dystrophy boys without cognitive impairment 72
Correction: Long-term natural history data in Duchenne muscular dystrophy ambulant patients with mutations amenable to skip exons 44, 45, 51 and 53 (PLoS ONE (2019) 14:6 (e0218683) DOI: 10.1371/journal.pone.0218683) 70
Cognitive profile in Duchenne muscular dystrophy boys without intellectual disability: The role of executive functions 68
null 64
Erratum: Long term natural history data in ambulant boys with duchenne muscular dystrophy: 36-month changes (PLoS ONE (2015) 10:12 (e0144079)) 60
Diagnosis of Duchenne Muscular Dystrophy in Italy in the last decade: Critical issues and areas for improvements 58
Genetic modifiers of respiratory function in Duchenne muscular dystrophy 57
Severe abnormalities of the pons in two infants with Goldenhar syndrome 56
Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls 51
The neurological examination of the newborn baby 49
Visual findings in infants with periventricular leukomalacia: 139 40
Visual development in infants with prenatal posthaemorrhagic ventricular dilatation 37
1st Italian SMA Family Association Consensus Meeting: Management and recommendations for respiratory involvement in spinal muscular atrophy (SMA) types I-III, Rome, Italy, 30-31 January 2015 12
1st Italian SMA Family Association Consensus Meeting: Management and recommendations for respiratory involvement in spinal muscular atrophy (SMA) types I-III, Rome, Italy, 30-31 January 2015 10
Totale 6.921
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.898
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.898
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021128 0 0 0 0 0 13 31 5 29 16 31 3
2021/2022384 19 17 19 41 25 15 7 64 29 23 61 64
2022/2023978 104 126 63 146 59 113 49 83 145 22 44 24
2023/2024635 36 131 20 40 25 134 61 18 5 23 63 79
2024/20251.373 24 26 99 45 123 73 53 56 176 109 326 263
2025/20262.302 464 115 256 466 748 253 0 0 0 0 0 0
Totale 6.921